Abstract |
A number of bis(diazeniumdiolates) that we designed to release up to 4 mol of nitric oxide (NO) and that are structural analogues of the NO prodrug and anticancer lead compound O(2)-{2,4-dinitro-5-[4-(N-methylamino)benzoyloxy]phenyl} 1-(N,N-dimethylamino)diazen-1-ium-1,2- diolate ( PABA/NO) were synthesized and studied. A majority of these compounds yielded higher levels of NO, were better inhibitors of proliferation of a number of cancer cell lines, and more rapidly induced substantially increased levels of S-glutathionylation of cellular proteins in comparison with PABA/NO. In most cases, the antiproliferative activity and extents of S-glutathionylation correlated well with levels of intracellular NO release. We report bis(diazeniumdiolates) to be a class of S-glutathionylating agents with potent antiproliferative and S-glutathionylating activity.
|
Authors | Daniela Andrei, Anna E Maciag, Harinath Chakrapani, Michael L Citro, Larry K Keefer, Joseph E Saavedra |
Journal | Journal of medicinal chemistry
(J Med Chem)
Vol. 51
Issue 24
Pg. 7944-52
(Dec 25 2008)
ISSN: 1520-4804 [Electronic] United States |
PMID | 19053760
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
|
Chemical References |
- Azo Compounds
- Nitric Oxide Donors
- Prodrugs
- diazeniumdiolate
- Nitric Oxide
- Glutathione
|
Topics |
- Azo Compounds
(chemistry, pharmacology)
- Cell Line, Tumor
- Cell Proliferation
- Chemistry, Pharmaceutical
(methods)
- Drug Design
- Drug Screening Assays, Antitumor
- Glutathione
(chemistry)
- HL-60 Cells
- Humans
- Inhibitory Concentration 50
- Models, Chemical
- Nitric Oxide
(chemistry)
- Nitric Oxide Donors
(chemistry)
- Prodrugs
(chemistry)
|